On Monday, August 23, the Food and Drug Administration (FDA) granted full approval to Pfizer-BioNTech’s COVID-19 vaccine for people 16 and older. This is the first COVID-19 vaccine to receive full approval in the United States. The FDA ruling should help overcome vaccine-hesitancy in some unvaccinated people who have stated this as their primary concern.

According to the FDA, the approved vaccine will now be marketed as Comirnaty to prevent COVID-19 disease in individuals 16 years of age and older. The vaccine will continue to be available to individuals ages 12-15 under emergency use au...